Drug firm Indivior plans to move primary listing to US in snub to London
Move is latest in number of delistings and IPO snubs to London Stock Exchange, including Tui
Stay updated with breaking news from Shaun Thaxter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Move is latest in number of delistings and IPO snubs to London Stock Exchange, including Tui
Indivior, the British drug maker, is to ditch its primary listing on the London Stock Exchange for New York in the latest blow to the Square Mile.
Indivior eyes more opportunity for opioid addiction treatments in US
Companies can struggle to give investors the full-on customer experience. Not Indivior, the drugs outfit treating opioid addiction. Since it was spun out of Reckitt in 2014, stock market life has been an upper and downer rollercoaster. Its key fixation? Pricey lawsuits, mainly linked to Suboxone Fil
Iowa Attorney General Brenna Bird joined 40 Attorney Generals across the country to accuse Indivior Inc. of monopolizing the opioid treatment market.